Back to mobile site

Brainstorm Cell Therapeutics (BCLI) Files $200M Mixed Shelf

August 9, 2021 5:00 PM EDT

Brainstorm Cell Therapeutics (NASDAQ: BCLI) files $200,000,000 mixed shelf.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Equity Offerings